Sabine Lauer

1.7k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Sabine Lauer is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Sabine Lauer has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in Sabine Lauer's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Breast Cancer Treatment Studies (5 papers). Sabine Lauer is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Breast Cancer Treatment Studies (5 papers). Sabine Lauer collaborates with scholars based in Germany, Switzerland and France. Sabine Lauer's co-authors include N. Al-Sakaff, Evandro de Azambuja, Martine Piccart, Luca Gianni, David Cameron, Eleanor McFadden, Mitch Dowsett, Marion Procter, Brian Leyland‐Jones and Aron Goldhirsch and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sabine Lauer

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

2017 688 citations David Cameron, Martine Piccart et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabine Lauer Germany	12	659	287	247	247	209	29	1.1k
Eun Jeong Lee South Korea	21	148 0.2×	137 0.5×	70 0.3×	222 0.9×	278 1.3×	69	1.2k
Teresa Morris United Kingdom	20	409 0.6×	257 0.9×	29 0.1×	75 0.3×	115 0.6×	36	979
Jo Anne Zujewski United States	14	1.1k 1.6×	461 1.6×	65 0.3×	380 1.5×	233 1.1×	23	1.3k
Javier Alonso Spain	26	490 0.7×	305 1.1×	213 0.9×	42 0.2×	403 1.9×	75	1.8k
Sheau‐Chiann Chen United States	22	592 0.9×	168 0.6×	32 0.1×	130 0.5×	381 1.8×	75	1.4k
Annabel Goodwin Australia	18	722 1.1×	396 1.4×	36 0.1×	85 0.3×	330 1.6×	45	1.1k
Raquel Nunes United States	14	816 1.2×	333 1.2×	139 0.6×	303 1.2×	164 0.8×	38	1.1k
Esha Jain United States	13	426 0.6×	268 0.9×	117 0.5×	25 0.1×	255 1.2×	35	1.1k
Noam Pondé Belgium	19	981 1.5×	488 1.7×	195 0.8×	212 0.9×	372 1.8×	52	1.4k
Daisy Dai United States	12	860 1.3×	117 0.4×	175 0.7×	41 0.2×	85 0.4×	20	1.7k

Countries citing papers authored by Sabine Lauer

Since Specialization

Citations

This map shows the geographic impact of Sabine Lauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Lauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Lauer more than expected).

Fields of papers citing papers by Sabine Lauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Lauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Lauer. The network helps show where Sabine Lauer may publish in the future.

Co-authorship network of co-authors of Sabine Lauer

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Lauer. A scholar is included among the top collaborators of Sabine Lauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Lauer. Sabine Lauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brom, Linda, Wendy M. van der Deure, Olaf P. Geerse, et al.. (2025). Timely integration of palliative care into oncology in hospitals in the Netherlands: a feasibility study. BMC Health Services Research. 25(1). 1231–1231. 1 indexed citations

Wilkesmann, Uwe & Sabine Lauer. (2025). Determinants of third-party funding applications in German academia. European Journal of Higher Education. 15(sup1). 82–102.

Lauer, Sabine & Uwe Wilkesmann. (2024). Determinants of Peer Review Acceptance: Motivational Insights From German Academia. Higher Education Quarterly. 79(1). 2 indexed citations

Lauer, Sabine & Uwe Wilkesmann. (2024). The Mediating Role of Basic Psychological Needs Satisfaction Between Transformational Leadership and Work Motivation of Predoctoral Researchers at German Professorships. Journal of Higher Education Theory and Practice. 24(8). 1 indexed citations

Anker, Stefan D., Leif Erik Sander, David Fitchett, et al.. (2022). Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease. Diabetes Research and Clinical Practice. 186. 109837–109837. 7 indexed citations

Ferreira, João Pedro, Subodh Verma, David Fitchett, et al.. (2020). Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial. Cardiovascular Diabetology. 19(1). 200–200. 22 indexed citations

Ferreira, João Pedro, David Fitchett, Anne Pernille Ofstad, et al.. (2020). Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial. American Journal of Hypertension. 33(12). 1092–1101. 27 indexed citations

Lauer, Sabine & Uwe Wilkesmann. (2019). How the institutional environment affects collegial exchange about teaching at German research universities: findings from a nationwide survey. Tertiary Education and Management. 25(2). 131–144. 5 indexed citations

Lidbrink, Elisabet, Ewa Chmielowska, Burkhard Otremba, et al.. (2018). A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study. Breast Cancer Research and Treatment. 174(1). 187–196. 30 indexed citations

10.

Wilkesmann, Uwe & Sabine Lauer. (2018). The influence of teaching motivation and New Public Management on academic teaching. Studies in Higher Education. 45(2). 434–451. 23 indexed citations

11.

Cameron, David, Martine Piccart, Richard D. Gelber, et al.. (2017). 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. The Lancet. 389(10075). 1195–1205. 688 indexed citations breakdown →

12.

Lidbrink, Elisabet, J. Erfán, Ewa Chmielowska, et al.. (2017). OHERA: A real world study of cardiac events in > 3700 patients with her2-positive early breast cancer treated with trastuzumab: Final analysis. Annals of Oncology. 28. v52–v52. 2 indexed citations

13.

Zardavas, Dimitrios, Thomas Suter, Dirk J. van Veldhuisen, et al.. (2017). Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy. Journal of Clinical Oncology. 35(8). 878–884. 107 indexed citations

14.

Gligorov, Joseph, Giuseppe Curigliano, Volkmar Müller, et al.. (2017). Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial. The Breast. 34. 89–95. 17 indexed citations

15.

Lidbrink, Elisabet, J. Erfán, Ewa Chmielowska, et al.. (2017). 1348P Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: results from two phase II studies.. 2 indexed citations

16.

Jung, Kyung Hae, Beyhan Ataseven, Mark Verrill, et al.. (2016). Adjuvant subcutaneous trastuzumab for HER2-positive early breast cancer: Phase III SafeHer study subgroup analyses of body weights, active medical conditions, safety and tolerability. Annals of Oncology. 27. vi63–vi63. 1 indexed citations

17.

Jackisch, C, M. Piccart, RD Gelber, et al.. (2016). Abstract PD5-01: HERA trial: 10 years follow up of trastuzumab after adjuvant chemotherapy in HER2 positive early breast cancer – Final analysis. Cancer Research. 76(4_Supplement). PD5–1. 8 indexed citations

18.

Ahn, Jin Seok, Christian Jackisch, Roberto Hegg, et al.. (2015). 55O_PR Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival by body weight and anti-drug antibody status. Annals of Oncology. 26. ix16–ix16. 1 indexed citations

19.

Wilkesmann, Uwe & Sabine Lauer. (2015). What affects the teaching style of German professors? Evidence from two nationwide surveys. Zeitschrift für Erziehungswissenschaft. 18(4). 713–736. 13 indexed citations

20.

Boulesteix, Anne‐Laure, Sabine Lauer, & Manuel J. A. Eugster. (2013). A Plea for Neutral Comparison Studies in Computational Sciences. PLoS ONE. 8(4). e61562–e61562. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact